glp-1 receptor agonist news Agonists as Treatments for Type 2 Diabetes Research shows GLP-1 receptor agonist

Danone: If anything, it will benefit our business For most companies, tactic #1 is the obvious starting point, with Daily Harvest recently debuting a GLP-1 Companion Food Collection featuring dietitian-curated meals to complement ones weight management journey and weight management app Noom positioning itself as a companion to help with adherence to the medication while avoiding muscle loss. Dairy giant Danone, meanwhile, says high-protein, low-fat dairy is ideal for Ozempic users, with deputy CEO Juergen Esser observing during the firms Q3 earnings call last year, that If anything, it [the more widespread use of GLP-1 drugs] will benefit our business. He added: People focusing on weight loss prefer obviously healthy products [according to Morgan Stanley research, Ozempic users are eating more fruit & veg and dairy and less confectionery, sugary drinks and alcohol]

In phase III trials, these agents have demonstrated an average A1C decrease of about 0.5% when administered as monotherapy

State court cases will continue independently but may still influence the broader litigation

Ocul Immunol Inflamm

Emerging multi-agonists such as retatrutide (GLP-1/GIP/glucagon triple agonist) and PTT-A (novel unimolecular peptide tetra-agonist targeting GLP-1, GIP, glucagon and amylin receptors) further expand this concept